Article ID Journal Published Year Pages File Type
1370164 Bioorganic & Medicinal Chemistry Letters 2011 7 Pages PDF
Abstract

The optimization of a new series of muscarinic M3 antagonists is described, leading to the identification of AZD9164 which was progressed into the clinic for evaluation of its potential as a treatment for COPD.

Graphical abstractThe optimization of a new series of muscarinic M3 antagonists is described, leading to the identification of AZD9164, which was progressed into the clinic for evaluation of its potential as a treatment for COPD.Figure optionsDownload full-size imageDownload as PowerPoint slide

Related Topics
Physical Sciences and Engineering Chemistry Organic Chemistry
Authors
, , , , , , , , , , ,